Curvebeam AI Ltd
ASX:CVB
Curvebeam AI Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.063
0.24
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Curvebeam AI Ltd hold over its rivals?
What risks and challenges
does Curvebeam AI Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Curvebeam AI Ltd.
Provide an overview of the primary business activities
of Curvebeam AI Ltd.
What unique competitive advantages
does Curvebeam AI Ltd hold over its rivals?
What risks and challenges
does Curvebeam AI Ltd face in the near future?
Summarize the latest earnings call
of Curvebeam AI Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Curvebeam AI Ltd.
Provide P/S
for Curvebeam AI Ltd.
Provide P/E
for Curvebeam AI Ltd.
Provide P/OCF
for Curvebeam AI Ltd.
Provide P/FCFE
for Curvebeam AI Ltd.
Provide P/B
for Curvebeam AI Ltd.
Provide EV/S
for Curvebeam AI Ltd.
Provide EV/GP
for Curvebeam AI Ltd.
Provide EV/EBITDA
for Curvebeam AI Ltd.
Provide EV/EBIT
for Curvebeam AI Ltd.
Provide EV/OCF
for Curvebeam AI Ltd.
Provide EV/FCFF
for Curvebeam AI Ltd.
Provide EV/IC
for Curvebeam AI Ltd.
Show me price targets
for Curvebeam AI Ltd made by professional analysts.
What are the Revenue projections
for Curvebeam AI Ltd?
How accurate were the past Revenue estimates
for Curvebeam AI Ltd?
What are the Net Income projections
for Curvebeam AI Ltd?
How accurate were the past Net Income estimates
for Curvebeam AI Ltd?
What are the EPS projections
for Curvebeam AI Ltd?
How accurate were the past EPS estimates
for Curvebeam AI Ltd?
What are the EBIT projections
for Curvebeam AI Ltd?
How accurate were the past EBIT estimates
for Curvebeam AI Ltd?
Compare the revenue forecasts
for Curvebeam AI Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Curvebeam AI Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Curvebeam AI Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Curvebeam AI Ltd compared to its peers.
Compare the P/E ratios
of Curvebeam AI Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Curvebeam AI Ltd with its peers.
Analyze the financial leverage
of Curvebeam AI Ltd compared to its main competitors.
Show all profitability ratios
for Curvebeam AI Ltd.
Provide ROE
for Curvebeam AI Ltd.
Provide ROA
for Curvebeam AI Ltd.
Provide ROIC
for Curvebeam AI Ltd.
Provide ROCE
for Curvebeam AI Ltd.
Provide Gross Margin
for Curvebeam AI Ltd.
Provide Operating Margin
for Curvebeam AI Ltd.
Provide Net Margin
for Curvebeam AI Ltd.
Provide FCF Margin
for Curvebeam AI Ltd.
Show all solvency ratios
for Curvebeam AI Ltd.
Provide D/E Ratio
for Curvebeam AI Ltd.
Provide D/A Ratio
for Curvebeam AI Ltd.
Provide Interest Coverage Ratio
for Curvebeam AI Ltd.
Provide Altman Z-Score Ratio
for Curvebeam AI Ltd.
Provide Quick Ratio
for Curvebeam AI Ltd.
Provide Current Ratio
for Curvebeam AI Ltd.
Provide Cash Ratio
for Curvebeam AI Ltd.
What is the historical Revenue growth
over the last 5 years for Curvebeam AI Ltd?
What is the historical Net Income growth
over the last 5 years for Curvebeam AI Ltd?
What is the current Free Cash Flow
of Curvebeam AI Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Curvebeam AI Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
C
|
Curvebeam AI Ltd
ASX:CVB
|
28.7m AUD | -1.9 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
220.2B USD | 20.8 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.7B USD | 53.1 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
157B USD | 36.4 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
154.2B USD | 26.6 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
119.1B USD | 14.2 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.8B EUR | 14.4 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
53.1B USD | 13.8 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD | 25 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.6B USD | 36.1 |
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.4B USD | 22 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
C
|
Curvebeam AI Ltd
ASX:CVB
|
Average EV/EBITDA:
26.2
|
N/A | N/A | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
20.8
|
13%
|
1.6 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
53.1
|
24%
|
2.2 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
36.4
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
26.6
|
12%
|
2.2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
14.2
|
7%
|
2 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14.4
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13.8
|
11%
|
1.3 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
25
|
12%
|
2.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
36.1
|
12%
|
3 |
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
22
|
12%
|
1.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.